Lonza CEO Pierre-Alain Ruffieux to Leave
Lonza CEO Pierre-Alain Ruffieux to Leave
Read moreDetailsLonza CEO Pierre-Alain Ruffieux to Leave
Read moreDetailsUpdated Sept. 9, 2023 10:51 am ETVivek Ramaswamy was a novice biotech entrepreneur in 2016 with no advanced medical training ...
Read moreDetailsText size Former Walgreens CEO Rosalind Brewer stepped down earlier this month. Valerie Plesch/Bloomberg Usually, the announcement of a CEO ...
Read moreDetailsText size Johnson & Johnson Benadryl brand allergy medication is now a part of Kenvue. Daniel Acker/Bloomberg Johnson & Johnson ...
Read moreDetailsText size Rivian Automotive saw its cash and cash equivalents decline by $6.6 billion last year. Patrick T. Fallon/AFP/Getty Images ...
Read moreDetailsThis copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or ...
Read moreDetailsResume Subscription We are delighted that you'd like to resume your subscription. You will be charged $ + tax (if ...
Read moreDetailsText size Nvidia is scheduled to report second-quarter earnings after the closing bell Wednesday. Dreamstime Stock futures traded higher Wednesday ...
Read moreDetailsText size Stock futures were rising modestly Wednesday. Dreamstime Stock futures pointed to a slightly higher start for Wall Street ...
Read moreDetailsText size Johnson & Johnson took the Kenvue consumer-health business public in May. Mark Ralston/Getty Images Johnson and Johnson ’s ...
Read moreDetailsEmail Contact: souhaib@trendswide.com